Judge Nixes Dismissal Bid In Thalomid Antitrust Suit

Law360, New York (March 31, 2011, 4:21 PM EDT) -- A federal judge in Pennsylvania on Thursday denied a second attempt by Celgene Corp. to dismiss an antitrust complaint by a generics maker that wants to market a version of the company's thalidomide-based cancer drug Thalomid.

The one-sentence order marks the second time Judge Timothy J. Savage of the U.S. District Court for the Eastern District of Pennsylvania has tossed a Celgene motion to dismiss Lannet Co.'s suit.

In its complaint filed in 2008, generic-drug maker Lannett accused Celgene of violating the Sherman Antitrust Act by...
To view the full article, register now.